Del Campo, Josep M <br/><br/>
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  11 2019 
 - 2968-2973 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.18.02238  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Indazoles--administration & dosage<br/>Maintenance Chemotherapy<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Organoplatinum Compounds--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Piperidines--administration & dosage<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Progression-Free Survival